JPMorgan Chase & Co. 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-07 2:45 pm Sale | 2023-11-30 | 13G | Heron Therapeutics, Inc. HRTX | JPMORGAN CHASE & CO JPM | 84,549 0.000% | -6,669,080 (-98.75%) | Filing |
| 2023-01-23 12:34 pm Purchase | 2022-12-30 | 13G | Heron Therapeutics, Inc. HRTX | JPMORGAN CHASE & CO JPM | 6,753,629 5.600% | 499,420 (+7.99%) | Filing |
| 2022-01-24 12:02 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | JPMORGAN CHASE & CO JPM | 6,254,209 6.100% | 6,254,209 (New Position) | Filing |